4//SEC Filing
Shanmugam Muthusamy 4
Accession 0001870913-25-000004
CIK 0001023024other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:21 PM ET
Size
7.0 KB
Accession
0001870913-25-000004
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2025-05-09$76.83/sh−700$53,781→ 631,920 total(indirect: By LLC)
Holdings
- 92,588
Common Stock
- 5,000(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024.
- [F2]The shares were sold in multiple trades at prices ranging from $76.11 to $76.95. The price reported above reflects the weighted average sales price.
- [F3]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F4]The reporting person holds voting and dispositive power over the shares held by SS Pharma LLC.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001870913
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:21 PM ET
- Size
- 7.0 KB